| Year |
Citation |
Score |
| 2009 |
Lowndes SA, Sheldon HV, Cai S, Taylor JM, Harris AL. Copper chelator ATN-224 inhibits endothelial function by multiple mechanisms. Microvascular Research. 77: 314-26. PMID 19323979 DOI: 10.1016/j.mvr.2009.01.003 |
0.41 |
|
| 2008 |
Lowndes SA, Adams A, Timms A, Fisher N, Smythe J, Watt SM, Joel S, Donate F, Hayward C, Reich S, Middleton M, Mazar A, Harris AL. Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7526-34. PMID 19010871 DOI: 10.1158/1078-0432.CCR-08-0315 |
0.402 |
|
| 2006 |
Lowndes SA, Harris AL. The role of copper in tumour angiogenesis. Journal of Mammary Gland Biology and Neoplasia. 10: 299-310. PMID 16924372 DOI: 10.1007/s10911-006-9003-7 |
0.442 |
|
| 2006 |
Lowndes SA, Adams A, Timms A, Middleton M, Hayward C, Reich SD, Mazar AP, Harris AL. Phase I study of ATN-224 in patients (pts) with advanced solid tumours Journal of Clinical Oncology. 24: 2065-2065. DOI: 10.1200/jco.2006.24.18_suppl.2065 |
0.387 |
|
| 2006 |
Doñate F, Lowndes S, Juarez J, Manuia M, Smith E, Liu N, Hayward C, Batuman O, Harris A, Mazar A. 132 POSTER Translation of in vitro markers of the anti-angiogenic and anti-tumor activity of the SOD1 inhibitor ATN-224 to clinical trials European Journal of Cancer Supplements. 4: 43. DOI: 10.1016/s1359-6349(06)70138-0 |
0.302 |
|
| 2004 |
Lowndes SA, Harris AL. Copper chelation as an antiangiogenic therapy Oncology Research. 14: 529-539. PMID 15666995 DOI: 10.3727/0965040042707952 |
0.443 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1996 |
Gazet JC, Coombes RC, Ford HT, Griffin M, Corbishley C, Makinde V, Lowndes S, Quilliam J, Sutcliffe R. Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer. British Journal of Cancer. 73: 758-62. PMID 8611376 DOI: 10.1038/bjc.1996.132 |
0.139 |
|
| 2003 |
Lowndes S, Darby A, Mead G, Lister A. Stevens-Johnson syndrome after treatment with rituximab. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 13: 1948-50. PMID 12453865 DOI: 10.1093/ANNONC/MDF350 |
0.137 |
|
| 2015 |
Hooper CE, Lyburn ID, Searle J, Darby M, Hall T, Hall D, Morley A, White P, Rahman NM, De Winton E, Clive A, Masani V, Arnold DT, Dangoor A, Guglani S, ... ... Lowndes SA, et al. The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication. British Journal of Cancer. 112: 1175-82. PMID 25756396 DOI: 10.1038/bjc.2015.62 |
0.131 |
|
| 2007 |
Lowndes S. Barristers on trial: Comprehension and misapprehension in courtroom discourse International Journal of Speech Language and the Law. 14. DOI: 10.1558/IJSLL.V14I2.305 |
0.12 |
|
| 2019 |
Vink P, Delgado Mingorance I, Maximiano Alonso C, Rubio-Viqueira B, Jung KH, Rodriguez Moreno JF, Grande E, Marrupe Gonzalez D, Lowndes S, Puente J, Kristeleit H, Farrugia D, McNeil SA, Campora L, Di Paolo E, et al. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial. Cancer. PMID 30707761 DOI: 10.1002/cncr.31909 |
0.119 |
|
| 2001 |
Gazet JC, Ford HT, Gray R, McConkey C, Sutcliffe R, Quilliam J, Makinde V, Lowndes S, Coombes RC. Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 12: 685-91. PMID 11432629 DOI: 10.1023/A:1011115107615 |
0.11 |
|
| 2010 |
Lowndes SA, Asher R, Middleton MR. Thyrotoxicosis with pegylated interferon alfa-2b. Archives of Dermatology. 146: 1273-5. PMID 21079065 DOI: 10.1001/archdermatol.2010.306 |
0.108 |
|
| 2015 |
Arnold DT, Hooper CE, Morley A, White P, Lyburn ID, Searle J, Darby M, Hall T, Hall D, Rahman NM, De Winton E, Clive A, Masani V, Dangoor A, Guglani S, ... ... Lowndes SA, et al. The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial. British Journal of Cancer. 112: 1183-9. PMID 25756395 DOI: 10.1038/bjc.2015.77 |
0.105 |
|
| 2005 |
Ford HT, Coombes RC, Gazet JC, Gray R, McConkey CC, Sutcliffe R, Quilliam J, Lowndes S. Long-term follow-up of a randomised trial designed to determine the need for irradiation following conservative surgery for the treatment of invasive breast cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 17: 401-8. PMID 16330517 DOI: 10.1093/ANNONC/MDJ080 |
0.097 |
|
| 2017 |
Wasan H, van Hazel G, Heinemann V, Sharma N, Taieb J, Ricke J, Peeters M, Findlay M, Virdee PS, Love S, Moschandreas J, Dutton P, Gebski V, Gray A, Price D, ... ... Lowndes S, et al. Overall survival analysis of the FOXFIRE-SIRFLOX-FOXFIRE global prospective randomized studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: iii148. PMID 32135786 DOI: 10.1093/annonc/mdx262.026 |
0.071 |
|
| 2005 |
Cathomas R, Lowndes S, Rogerson M, Gregory K. Primary peritoneal carcinoma with acute renal failure: successful treatment with chemotherapy. Clinical Oncology (Royal College of Radiologists (Great Britain)). 17: 69-70. PMID 15714937 DOI: 10.1016/J.CLON.2004.05.009 |
0.043 |
|
| 2010 |
Lowndes S. Tokens of Sense: The Work of Thea Djordjadze Afterall: a Journal of Art, Context and Enquiry. 23: 72-81. DOI: 10.1086/aft.23.20711782 |
0.01 |
|
| Hide low-probability matches. |